title: Effects of inhaled corticosteroids on bone.
abstract: OBJECTIVE
  To discuss the effects of inhaled corticosteroids on bone and their potential public health implications.
  
  
  METHODS
  The MEDLINE and EMBASE databases were searched to identify articles published between 1966 and January 2004 with the following keywords in the title: inhaled corticosteroid, beclomethasone, budesonide, flunisolide, fluticasone, mometasone, triamcinolone plus bone, fracture, osteoporosis, osteocalcin, growth, or height.
  
  
  METHODS
  Key studies of adequate size and duration that allowed for potential confounding factors where required were selected.
  
  
  RESULTS
  Inhaled corticosteroids are absorbed into the systemic circulation and therefore have the potential to cause adverse effects on bone. Several of the larger studies showed that inhaled corticosteroids cause a dose-related reduction in bone mineral density. Three cross-sectional studies found a dose-related increase in fractures in people taking an inhaled corticosteroid compared with controls. Prospective studies found a short-term reduction in growth velocity in children taking an inhaled corticosteroid, although target adult height is usually achieved.
  
  
  CONCLUSIONS
  Since osteoporotic fracture is common in elderly patients and up to 5% of the population in more developed countries take an inhaled corticosteroid, these findings have public health implications. Strategies are needed to reduce the systemic effects of inhaled corticosteroids.
authors.affiliation: Division of Respiratory Medicine, Nottingham University City Hospital, Nottingham, England. Kevin.Mortimer@nottingham.ac.uk
authors.forename: K J
authors.initials: KJ
authors.lastname: Mortimer
authors.forename: T W
authors.initials: TW
authors.lastname: Harrison
authors.forename: A E
authors.initials: AE
authors.lastname: Tattersfield
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage* / Q000009:adverse effects*; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D001249:Asthma / Q000188:drug therapy* / Q000378:metabolism; D015519:Bone Density / Q000187:drug effects; D016723:Bone Remodeling / Q000187:drug effects; D001842:Bone and Bones / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D005260:Female; D050723:Fractures, Bone / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced / Q000378:metabolism
chemical_list: D000305:Adrenal Cortex Hormones; D018927:Anti-Asthmatic Agents